Related content

Pharmacoeconomic aspects of personalized medicine Pharmakoökonomische Aspekte der stratifizierten Pharmakotherapie

By Frank Martin   Prenzler Anne  

PHARMAKON, Vol. 1, Iss. 1, 2013-01 ,pp. : 61-66

Govi-Verlag

Access to resources Recommend Favorite

Pharmacogenomic biomarkers for personalized medicine

By Chen James J   Lin Wei-Jiun   Chen Hung-Chia  

Pharmacogenomics, Vol. 14, Iss. 8, 2013-06 ,pp. : 969-980

Future Medicine

Access to resources Recommend Favorite

Biomarker Diversity, Validation and Clinical Translation: Tenets for Emergent Personalized Medicine Initiatives

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 4, 2011-12 ,pp. : 286-298

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Biomarker Translation and Personalized Medicine - Context, Reality and a Call for Enhanced Validation]

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 8, Iss. 3, 2010-09 ,pp. : 171-173

Bentham Science Publishers

Access to resources Recommend Favorite

Identifying High-Dimensional Biomarkers for Personalized Medicine via Variable Importance Ranking

By Baek Songjoon  

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 5, 2008-09 ,pp. : 853-868

Taylor & Francis Ltd

Access to resources Recommend Favorite